L11.0 Acquired keratosis follicularis

Name of the Condition

• Acquired keratosis follicularis

Summary

Acquired keratosis follicularis is a skin condition characterized by the development of keratotic papules and plaques, typically involving hair follicles. It may present with hyperkeratotic lesions, scaling, and potential inflammation, affecting areas such as the trunk, extremities, or face. The condition is distinct from congenital forms and arises later in life.

Causes

The exact cause of acquired keratosis follicularis is not fully understood, but it may be associated with underlying systemic conditions, medications, or environmental factors. It can occur secondary to other dermatologic or systemic diseases, though specific triggers vary among individuals.

Risk Factors

• Underlying systemic diseases (e.g., autoimmune disorders, malignancies)
• Certain medications (e.g., chemotherapy agents, immunosuppressants)
• Chronic skin irritation or trauma
• Genetic predisposition (in some cases)
• Advanced age

Symptoms

• Small, rough, keratotic papules or plaques
• Scaling or hyperkeratosis of affected areas
• Possible itching or mild discomfort
• Distribution along hair follicles or body folds
• Variable severity depending on underlying causes

Diagnosis

Diagnosis is typically made through clinical evaluation, including a physical examination of the skin lesions. A biopsy may be performed to confirm the histopathologic features, ruling out other keratotic or inflammatory conditions. Laboratory tests may be used to identify associated systemic factors.

Treatment Options

• Topical keratolytics (e.g., salicylic acid, retinoids) to reduce scaling
• Emollients to soothe dryness and irritation
• Addressing underlying causes (e.g., discontinuing offending medications)
• Systemic therapies for severe or refractory cases
• Regular monitoring for changes in lesion appearance

Prognosis and Follow-Up

Prognosis depends on the underlying cause and response to treatment. Lesions may persist or resolve with appropriate management. Follow-up is recommended to monitor for complications, assess treatment efficacy, and address any evolving symptoms.

Complications

• Secondary bacterial or fungal infections
• Persistent scarring or hyperpigmentation
• Discomfort or pruritus affecting quality of life
• Progression if underlying conditions are unmanaged

Lifestyle & Prevention

• Maintain good skin hygiene to reduce irritation
• Avoid known triggers (e.g., harsh soaps, friction)
• Protect skin from excessive sun exposure
• Follow prescribed treatment regimens consistently
• Report new or worsening symptoms promptly

When to Seek Professional Help

Seek medical attention if lesions become painful, infected, or widespread, or if symptoms interfere with daily activities. Prompt evaluation is advised for persistent or unresponsive cases to rule out underlying conditions.

Tips for Medical Coders

When coding for acquired keratosis follicularis (L11.0), ensure documentation supports the diagnosis, including clinical findings and any associated factors. Verify that the condition is not congenital or linked to other specified disorders to avoid miscoding. Accurate coding requires clear differentiation from similar keratotic conditions.